Suven Life gets 3 product patents for NCEs

G Naga Sridhar Hyderabad | Updated on March 24, 2015 Published on March 24, 2015

Suven Life Sciences Ltd has secured three product patents for its new chemical entities in Canada, Japan and Korea.

The NCEs are associated with drugs useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention Deficient Hyperactivity Disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia, the Hyderabad-based company said in a release issued here on Tuesday.

The company’s scrip gained 6.5 per cent and is trading at Rs 297.80 on the Bombay Stock Exchange on Tuesday.

Published on March 24, 2015
This article is closed for comments.
Please Email the Editor